The FDA cracked down on sweet vapes after kids’ use spiked. Now, Supreme Court wades in
Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, ...
Doctors warn against dangerous new sex trend making its way through college campuses
A troubling sex trend is making its way across college campuses nationwide, and doctors are concerned. Healthy college men ...
Dr Reddy's launches India's first immuno-oncology drug to treat rare form of head and neck cancer
With this launch, India has become the third country in the world, after China and the US, to receive access to this ...
FOX 5 Atlanta11h
Emory doctors first in U.S. to successfully perform new 'experimental' heart pump surgery
Doctors at Emory University Healthcare made history by becoming the first group in the U.S. to successfully implant a new ...
Bolivia's top court says its former anti-drug chief can be extradited to the US on drug charges
Bolivia's highest court on Wednesday approved the extradition to the United States of a former anti-narcotics chief on ...
The “Holiday Pause” For GLP-1s Is Quickly Approaching — but Is It Safe?
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...
US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
JD Supra20h
FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research
A recent article authored by Haider J. Warraich, MD; Troy Tazbaz; and Robert M. Califf, MD in the Journal of the American ...
Peninsula Daily News20h
Gluco Guard Scam Claims: What Reviews Reveal About Its Marketing Tactics
In an era where health and wellness take center stage, finding effective solutions for managing blood sugar levels has become ...
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...
BioPharma Dive22h
Sarepta rebuilds drug pipeline with Arrowhead deal
A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...
Medscape1d
Hidradenitis Suppurativa: Drug Survival Rates in Pediatric Patients Compared
The drug survival for adalimumab is significantly higher than that of infliximab in pediatric patients with hidradenitis suppurativa (HS), results from a small single-center study showed.